Table 3.
No Missing Mean | Covariates Std | With Missing Mean | Covariates Std | Δ p-value | |
---|---|---|---|---|---|
N | 71,999 | 102202 | |||
Metformin Use (%) | 38.80 | 14.59 | <0.001 | ||
Statin Use (%) | 78.17 | 52.23 | <0.001 | ||
Finasteride Use (%) | 13.68 | 9.56 | <0.001 | ||
Study Length (days) | 2339.86 | 1009.37 | 1838.27 | 1268.99 | <0.001 |
PCa (%) | 5.22 | 5.68 | <0.001 | ||
Age | 66.91 | 10.22 | 71.94 | 10.15 | <0.001 |
Black (%) | 17.74 | 14.87 | <0.001 | ||
Charlson | 3.91 | 2.71 | 3.04 | 2.50 | <0.001 |
Baseline A1c | 6.51 | 0.96 | 6.65 | 1.16 | <0.001 |
Mean A1c | 6.57 | 0.90 | 6.52 | 1.02 | <0.001 |
ΔA1C | 0.06 | 0.83 | −0.02 | 0.95 | <0.001 |
Baseline LDL | 106.71 | 27.09 | 105.06 | 28.92 | <0.001 |
Mean LDL | 89.22 | 25.00 | 90.29 | 26.95 | <0.001 |
ΔLDL | −17.49 | 24.77 | −14.96 | 27.35 | <0.001 |
Baseline BMI | 30.98 | 4.98 | 30.54 | 7.01 | <0.001 |
ΔBMI | −1.02 | 3.15 | −0.96 | 9.88 | 0.02 |
Maximum PSA | 2.64 | 5.20 | 3.60 | 7.71 | <0.001 |